(Q47813139)
Statements
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA (English)
Stefaan C De Smedt
Laura Wayteck
Benedicte Descamps
scientific article published on 4 October 2017